Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02734940 · ClinicalTrials.gov registry record · Phase 4
Multimodal Analgesia in Cardiac Surgery (Pilot Study)
A Phase 4 study, sponsored by Virginia Commonwealth University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 3
- Enrollment target
NCT02734940: Clinical Trial Phase 4 study, sponsored by Virginia Commonwealth University.
NCT02734940 is a Phase 4 study that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 3 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02734940, a Phase 4 study, was terminated before completion, sponsored by Virginia Commonwealth University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 3 participants
- Enrollment target
Study Summary
The investigators objective is to assess the effectiveness of an opioid sparing multimodal approach for enhancing the recovery in Cardiac Surgical patients. This model would use a combination of intravenous (Dexmedetomidine, Ketamine, Lidocaine) and Spinal (Morphine) drugs.
Primary Outcome
Pain scores recorded 24 hours post extubation by acute pain services nurses (who will be blinded)
Interventions
- DRUG Ketamine
- DRUG Lidocaine
- DRUG Precedex
- DRUG Unrestricted Fentanyl
- DRUG Duramorph
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2016-07-11 |
| Est. Completion | 2017-02-01 |
| Phase | Phase 4 |
Why NCT02734940 stopped before completion
NCT02734940 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Ketamine is the first listed.
NCT02734940 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02734940 about?
NCT02734940 is a clinical study titled "Multimodal Analgesia in Cardiac Surgery (Pilot Study)". The investigators objective is to assess the effectiveness of an opioid sparing multimodal approach for enhancing the recovery in Cardiac Surgical patients. This model would use a combination of intravenous (Dexmedetomidine, Ketamine, Lidocaine) and Spinal (Morphine) drugs.
What is the current status of trial NCT02734940?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 3 participants. The study started on 2016-07-11. Estimated completion is 2017-02-01.
What interventions are being tested in trial NCT02734940?
The interventions under investigation include: Ketamine (DRUG), Lidocaine (DRUG), Precedex (DRUG), Unrestricted Fentanyl (DRUG), Duramorph (DRUG).
Who is sponsoring clinical trial NCT02734940?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02734940's enrollment target sits among peer trials
3 1995th of 2000 higher than 3 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI